George Yaghmour

Title(s)Associate Professor of Clinical Medicine
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard
    Other Positions
    Title(s)Associate Director, Allogeneic Bone Marrow Transplant


    Collapse Biography 
    Collapse awards and honors
    Los Angeles Magazine2017Top Doctors in Southern CA Rising Stars
    Tennessee Oncology Practice Society2015Outstanding Fellow Award
    Asheville Hematologic Malignancies Symposium2015Scholarship Award
    VAMC Memphis2014Star Team Award
    Wayne State University, Henry Ford Hospital 2013Recognized and Ranked Top 5% Internal Medicine Residents
    Henry Ford Hospital2012Outstanding Patient Satisfaction/ Care
    Aleppo University School of Medicine2008Top 1% Graduate Award

    Collapse Overview 
    Collapse overview
    George Yaghmour, MD has joined the Jane Anne Nohl Division of Hematology as Assistant Professor of Clinical Medicine. Dr. Yaghmour will be working specifically in the areas of Acute Leukemia and Allogeneic Stem Cell Transplantation. He graduated from University of Aleppo, Syria. He performed his residency training in Internal Medicine at Henry Ford Hospital/Wayne State University and then joined University of Tennessee Health Sciences Center/West Cancer Center in Memphis, TN for a clinical fellowship in Hematology and Medical Oncology. He is board certified in Internal Medicine, Hospital Medicine, Hematology and Medical Oncology.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia. Blood Adv. 2025 May 13; 9(9):2144-2152. Pyzer AR, Dillon LW, Sharon E, Karrison TG, Zha Y, Fulton N, Gui G, Andrew G, Streicher H, Sweet K, Yaghmour G, Liu JJ, Jonas BA, Schimmer AD, Grant S, Zeidan AM, Hildebrandt GC, Lowrey CH, Mattison RJ, Palmisiano N, Salhotra A, Tzachanis D, Baer MR, Lin TL, Patel P, Chen H, Stadler WM, Odenike O, Larson RA, Gajewski TF, Hourigan CS, Stock W, Liu H. PMID: 39928953; PMCID: PMC12051614.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia. EJHaem. 2025 Jun; 6(3):e70051. Mannis GN, Abboud CN, Daver NG, Murthy GSG, Wang ES, Bradley TJ, Yaghmour G, Vachhani P, Balasubramanian SK, Chua CC, Fong CY, Asch AS, Dong M, Li S, Bagheri T, Doshi P, Vyas P, Malki MMA. PMID: 40364806; PMCID: PMC12073901.
      View in: PubMed   Mentions:
    3. Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy. Blood Adv. 2025 Mar 24. Lust H, Schultz LM, Kwon S, Roloff GW, Aldoss I, Baggott C, John S, Rossoff J, McNerney KO, Fabrizio VA, Talano JA, Moskop A, Curran KJ, Phillips CL, Karras NA, Baumeister SHC, Cooper S, Hermiston ML, Satwani P, Qayed M, Raikar SS, MacMillan ML, Hall EM, Nguyen K, Cassaday RD, Kopmar NE, Kota VK, Mathews J, Shaughnessy PJ, Schwartz MS, Ladha A, Yaghmour G, Kumaran M, Bachanova V, Tracy SI, Othman T, Luskin MR, Chen EC, Advani AS, Jeyakumar N, Miller K, Zhang A, Shah BD, Muffly LS, Faramand RG. PMID: 40127395.
      View in: PubMed   Mentions:    Fields:    
    4. Combination of 2-Chlorodeoxyadenosine, Cytarabine, and Granulocyte Colony-Stimulating Factor and Venetoclax in a Case of Acute Myelogenous Leukemia. J Med Cases. 2025 Mar; 16(3):102-106. Jackert EP, Woan K, Chaudhary P, Yaghmour G, Ladha A, Tam E. PMID: 40160192; PMCID: PMC11954599.
      View in: PubMed   Mentions:
    5. Combination Therapy With Asciminib and Ponatinib as a Bridge to Brexucabtagene Autoleucel and Maintenance in a Patient With Relapsed Refractory Philadelphia Positive B-Cell Acute Lymphoblastic Leukemia. J Med Cases. 2024 Oct; 15(10):261-266. Amin Muhammad A, Mir Ghazi E, Ali A, Tam E, Woan K, Chaudhary P, Yaghmour G, Ladha A. PMID: 39328803; PMCID: PMC11424108.
      View in: PubMed   Mentions: 1  
    6. Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapy. Br J Haematol. 2024 Dec; 205(6):2234-2247. Ashouri K, Hom B, Ginosyan AA, Rahimi Y, Resnick K, Nittur V, Hwang J, Ireland R, Ann B, Adnani B, Bragasin EI, Chaudhary P, Ali A, Woan K, Tam EL, Siddiqi I, Ladha A, Yaghmour G. PMID: 39295195.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    7. CAST Regimen for GvHD Prophylaxis: A CIBMTR Propensity Score-Matched Analysis. Transplant Cell Ther. 2024 Nov; 30(11):1092-1098. Al-Homsi AS, DeFor TE, Cole K, Cirrone F, King S, Suarez-Londono A, Yaghmour G, Boisclair S, Bupp C, Spellman SR. PMID: 39209024.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus. Transplant Proc. 2024 Sep; 56(7):1671-1677. Ashouri K, Fernandez E, Ginosyan A, Feliciano CM, Hom B, Rodman J, Ali A, Ladha A, Woan K, Tam E, Chaudhary P, Yaghmour G. PMID: 39174390.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study. Leuk Res. 2024 Jun; 141:107501. Ashouri K, Ginosyan AA, Chu M, Hom B, Hwang J, Resnick K, Rahimi Y, Chaudhary P, Woan K, Siddiqi I, Ladha A, Ali A, Tam EL, Yaghmour G. PMID: 38631149.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Post-stem cell transplant maintenance in FLT3mut acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib. EJHaem. 2024 Apr; 5(2):423-427. Ashouri K, Chennapan K, Martynova A, Nazaretyan S, Ali A, Ginosyan AA, Tam E, Ladha A, Woan K, Chaudhary P, Siddiqi I, Yaghmour G. PMID: 38633126; PMCID: PMC11020142.
      View in: PubMed   Mentions: 1  
    11. Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease. Front Oncol. 2024; 14:1329893. Cai Y, Ali A, Filler E, Bayati R, Toma T, Zaki O, Yaghmour G, Ladha A, Woan K, Tam E, Chaudhary PM. PMID: 38410106; PMCID: PMC10894980.
      View in: PubMed   Mentions:
    12. Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing Prediction of Clinical Outcomes From a Single-Center Study. Clin Lymphoma Myeloma Leuk. 2024 03; 24(3):e59-e66.e2. Ashouri K, Nittur V, Ginosyan AA, Hwang J, Adnani B, Chen D, Savitala-Damerla L, Schiff K, Chaudhary P, Kovach AE, Ladha A, Siddiqi I, Ali A, Woan K, Tam E, Yaghmour G. PMID: 38061959.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review. Respir Med Case Rep. 2023; 46:101922. Nazaretyan S, Ali A, Yaghmour G, Tong A, Castillo V, Rodrigues S, Ladha A, Woan K, Tam E, Shi SY, Bateshansky D, Chaudhary PM. PMID: 37841284; PMCID: PMC10570145.
      View in: PubMed   Mentions:
    14. Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment. Cell Mol Biol Lett. 2023 May 24; 28(1):45. Meng Y, Pospiech M, Ali A, Chandwani R, Vergel M, Onyemaechi S, Yaghmour G, Lu R, Alachkar H. PMID: 37226083; PMCID: PMC10210361.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    15. Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia. Blood Adv. 2023 04 11; 7(7):1279-1285. Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park J, Wieduwilt M, Jeyakumar D, Yaghmour G, Atallah EL, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow M, Stone RM, Sharon E, Erba HP. PMID: 36322825; PMCID: PMC10090098.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert Opin Drug Metab Toxicol. 2023 Jan-Jun; 19(6):357-366. Alqahtani A, Alhousari D, Ali A, Yaghmour G, Orgel E, Curran E, Stock W, Bhojwani D, Alachkar H. PMID: 37410014; PMCID: PMC11516125.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis. Transpl Immunol. 2023 02; 76:101769. Dwabe S, Hsiao M, Ali A, Rodman J, Savitala-Damerla L, Nazaretyan S, Kimberly Schiff NP, Tam E, Ladha A, Woan K, Chaudhary P, Yaghmour G. PMID: 36464218.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. A novel approach to describing the pancreas and submandibular gland: Can they be classified as primary and secondary tissue organs? Acta Histochem. 2022 Aug; 124(6):151934. Theodory B, Cao T, Swisher AR, Pham R, DiPatrizio NV, Yaghmour G. PMID: 35908509.
      View in: PubMed   Mentions:    Fields:    
    19. Hepatitic Variant of Graft-vs-Host Disease. Am J Clin Pathol. 2022 06 07; 157(6):948-955. Liang TZ, Dong S, Fang M, Gong Y, Yaghmour G, Chopra S. PMID: 35038720.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Unique Challenges to Diagnosing Human Herpesvirus-6 (HHV-6) Encephalitis Following Post-Hematopoietic Stem Cell Transplant: A Case and Brief Review. Cell Transplant. 2022 Jan-Dec; 31:9636897221119734. Zhu H, Ali A, Woan KV, Tam E, Yaghmour G, Flores A, Chaudhary P. PMID: 36927092; PMCID: PMC9478732.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. Am J Hematol. 2021 03 01; 96(3):E59-E63. Arslan S, Zhang J, Dhakal P, Moran J, Naidoo N, Lombardi J, Pullarkat V, Stein AS, Marcucci G, Yaghmour G, Bhatt VR, Fathi AT, Aldoss I. PMID: 33227142.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    22. First reported case of BRAF V600E mutation in T-cell prolymphocytic leukaemia. Br J Haematol. 2020 10; 191(2):e52-e55. Dong S, Khedro T, Ward P, Dubeau L, Yaghmour B, Siddiqi I, Yaghmour G. PMID: 32712959; PMCID: PMC9007147.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review. World J Oncol. 2020 Jun; 11(3):112-115. Hsiao M, Tatishchev S, Khedro T, Yaghmour B, O'Connell C, Yaghmour G. PMID: 32494318; PMCID: PMC7239570.
      View in: PubMed   Mentions: 2  
    24. Acute Respiratory Events and Dosimetry of Total Body Irradiation Patients Using In Vivo Lung Dose Monitoring and Custom Lung Block Adaptation. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e397-e405. Jang JK, Reilly M, Yaghmour G, Rashid F, Ballas LK. PMID: 32315783.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab. World J Oncol. 2020 Feb; 11(1):41-43. Wang L, Bargout M, Hon JD, Yaghmour B, Mohrbacher A, Yaghmour G. PMID: 32095189; PMCID: PMC7011905.
      View in: PubMed   Mentions: 1  
    26. Bone Marrow Features in Patients With Acute Myeloid Leukemia Treated With Novel Targeted Isocitrate Dehydrogenase 1/2 Inhibitors. World J Oncol. 2019 Dec; 10(6):226-230. Hagiya A, Vaidya P, Khedro T, Yaghmour B, Siddiqi I, Yaghmour G. PMID: 31921378; PMCID: PMC6940036.
      View in: PubMed   Mentions: 1  
    27. Midostaurin-Related Interstitial Lung Injury in FLT3+ Acute Myeloid Leukemia Post-Allogeneic Transplant. World J Oncol. 2019 Dec; 10(6):237-239. Vaidya P, Khedro T, Yaghmour B, Yaghmour G. PMID: 31921380; PMCID: PMC6940037.
      View in: PubMed   Mentions: 3  
    28. Aggressive systemic mastocytosis: midostaurin is safe, feasible and associated with durable response post-haploidentical allogeneic stem cell transplant. Br J Haematol. 2019 09; 186(5):e139-e141. Martynova A, Nael A, O Neill C, Ramsingh G, Merchant A, Yaghmour B, Yaghmour G. PMID: 31111479.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Combination chemotherapy plus dasatinib leads to comparable overall survival and relapse-free survival rates as allogeneic hematopoietic stem cell transplantation in Philadelphia positive acute lymphoblastic leukemia. Cancer Med. 2019 06; 8(6):2832-2839. Chang J, Douer D, Aldoss I, Vahdani G, Jeong AR, Ghaznavi Z, Zhang S, Yaghmour G, Lee KJ, Weissman A, Akhtari M. PMID: 31016870; PMCID: PMC6558592.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    30. Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2019 01; 173(1):243. McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein MK, Feldman R, Chandler JC, Martin MG. PMID: 30306431.
      View in: PubMed   Mentions: 1     Fields:    
    31. A Case of Recurrent Pregnancy-Induced Adult Onset Familial Hemophagocytic Lymphohistiocytosis. World J Oncol. 2018 Aug; 9(4):123-127. Wang LY, Hu J, Ramsingh G, Theodory B, Yaghmour B, Vergara-Lluri M, Yaghmour G. PMID: 30220951; PMCID: PMC6134992.
      View in: PubMed   Mentions: 8  
    32. The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant. Leuk Res Rep. 2018; 10:26-36. Li GX, Wang L, Yaghmour B, Ramsingh G, Yaghmour G. PMID: 30112274; PMCID: PMC6092446.
      View in: PubMed   Mentions: 6  
    33. Impact of Provider Volume on Outcomes of Patients With Hodgkin Lymphoma. World J Oncol. 2018 Apr; 9(2):46-49. Ireland C, Wiedower E, Mirza M, Crawley M, Tran A, Yaghmour G, Martin MG. PMID: 29760832; PMCID: PMC5942207.
      View in: PubMed   Mentions: 2  
    34. Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia. Leuk Res Rep. 2018; 9:18-20. Punwani N, Merin N, Mohrbacher A, Yaghmour G, Sano A, Ramezani L, Chaudhary PM, Ramsingh G. PMID: 29556468; PMCID: PMC5856665.
      View in: PubMed   Mentions: 3  
    35. The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis. Br J Haematol. 2017 11; 179(4):618-626. Igwe IJ, Yang D, Merchant A, Merin N, Yaghmour G, Kelly K, Ramsingh G. PMID: 29047122; PMCID: PMC7546179.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    36. Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality. Anticancer Res. 2017 02; 37(2):813-817. Prouet P, Giri S, Wiedower E, Fintel A, Yaghmour G, Lamb EP, Deneve J, Fleming M, Dickson P, Chandler JC, Martin MG. PMID: 28179335.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine. Ther Adv Hematol. 2017 Feb; 8(2):91-95. Yaghmour G, Wiedower E, Yaghmour B, Nunnery S, Duncavage E, Martin MG. PMID: 28203345; PMCID: PMC5298388.
      View in: PubMed   Mentions: 3  
    38. Genomic alterations in neuroendocrine cancers of the ovary. J Ovarian Res. 2016 Aug 26; 9(1):52. Yaghmour G, Prouet P, Wiedower E, Jamy OH, Feldman R, Chandler JC, Pandey M, Martin MG. PMID: 27566252; PMCID: PMC5002197.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    39. Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. Anticancer Res. 2016 Aug; 36(8):4033-8. Yaghmour G, Pandey M, Ireland C, Patel K, Nunnery S, Powell D, Baum S, Wiedower E, Schwartzberg LS, Martin MG. PMID: 27466509.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016 07; 158(1):195-202. McCullar B, Pandey M, Yaghmour G, Hare F, Patel K, Stein K, Feldman R, Chandler JC, Martin MG. PMID: 27329168.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    41. Under-recognition of hemophagocytic syndrome in United States' rural, non-teaching hospitals. Leuk Lymphoma. 2016 12; 57(12):2911-2913. Jamy O, Nunnery S, Giri S, Wiedower E, Johnson B, Yaghmour G, Martin MG. PMID: 27087428.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome. Clin Lymphoma Myeloma Leuk. 2016 Apr; 16(4):230-6. Johnson B, Giri S, Nunnery SE, Wiedower E, Jamy O, Yaghmour G, Chandler JC, Martin MG. PMID: 26837475.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):646-54. Hahn AW, Jamy O, Nunnery S, Yaghmour G, Giri S, Pathak R, Martin MG. PMID: 26386907.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    44. Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary. Anticancer Res. 2015 May; 35(5):3091-5. Jamy O, Yaghmour G, Hare F, Martin MG. PMID: 25964600.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Early mortality in acute myeloid leukemia. Leuk Res. 2015 May; 39(5):505-9. Hahn A, Giri S, Yaghmour G, Martin MG. PMID: 25726083.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Ibrutinib has some activity in Richter's syndrome. Blood Cancer J. 2015 Jan 30; 5:e277. Giri S, Hahn A, Yaghmour G, Martin MG. PMID: 25635530; PMCID: PMC5404220.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. Drug-Induced Aseptic Meningitis Associated With Intrathecal Trastuzumab. J Pharm Technol. 2014 Apr; 30(2):43-47. Freyer CW, Yaghmour G, Jennings K, Dhanapal V. PMID: 34860873; PMCID: PMC5990126.
      View in: PubMed   Mentions: 3  
    48. All that glitters is not gold: differential diagnosis of clover-leaf lymphocytes. Int J Hematol. 2013 Jun; 97(6):679-80. Yaghmour G, Thind R, Kryvenko ON, Ayyad H, Chen A, Kuriakose P. PMID: 23625610.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    George's Networks
    Concepts (156)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.